Literature DB >> 8561201

Functioning and well-being of patients with panic disorder.

C D Sherbourne1, K B Wells, L L Judd.   

Abstract

OBJECTIVE: The authors compared the health-related quality of life of patients with panic disorder to that of patients with other major chronic medical and psychiatric conditions.
METHOD: The physical and mental health of a group of 433 patients with current panic disorder and 9,839 outpatients with psychiatric or medical disorders were assessed with the 20- and 36-item short-form surveys of the Medical Outcomes Study. After controlling for other disease conditions, demographics, and study site, the authors used multiple regression methods to estimate health-related quality of life levels for panic disorder patients and patients with hypertension, diabetes, heart disease, arthritis, chronic lung problems, and major depression.
RESULTS: Patients with panic disorder had levels of mental health and role functioning that were substantially lower than those of patients with other major chronic medical illnesses but were higher than or comparable to those of patients with depression. However, their physical functioning levels and perceptions of current health were more like those of patients with hypertension and were similar to general population norms.
CONCLUSIONS: Panic disorder is a serious societal health problem with large consequences, and it affects primarily psychological and role domains.

Entities:  

Mesh:

Year:  1996        PMID: 8561201     DOI: 10.1176/ajp.153.2.213

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 2.  Quality of life in panic disorder: looking beyond symptom remission.

Authors:  Julia Davidoff; Scott Christensen; David N Khalili; Jaidyn Nguyen; Waguih William IsHak
Journal:  Qual Life Res       Date:  2011-09-21       Impact factor: 4.147

3.  Cost effectiveness of acute imipramine therapy versus two imipramine maintenance treatment regimens for panic disorder.

Authors:  M R Mavissakalian; J K Schmier; J A Flynn; D A Revicki
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

4.  Validity and reliability of the Italian version of the Quality of Life, Enjoyment and Satisfaction Questionnaire.

Authors:  A Rossi; P Rucci; M Mauri; G Maina; F Pieraccini; S Pallanti; J Endicott
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

5.  The health-related quality of life in eating disorders.

Authors:  A Padierna; J M Quintana; I Arostegui; N Gonzalez; M J Horcajo
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

6.  Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysis.

Authors:  Stefan G Hofmann; Jade Q Wu; Hannah Boettcher
Journal:  J Consult Clin Psychol       Date:  2014-01-20

7.  The Impact of the Unified Protocol for Emotional Disorders on Quality of Life.

Authors:  Matthew W Gallagher; Shannon E Sauer-Zavala; James F Boswell; Jenna R Carl; Jackie Bullis; Todd J Farchione; David H Barlow
Journal:  Int J Cogn Ther       Date:  2013-03-01

8.  Health-related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions (NESARC).

Authors:  Jonathan S Comer; Carlos Blanco; Deborah S Hasin; Shang-Min Liu; Bridget F Grant; J Blake Turner; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2010-08-24       Impact factor: 4.384

9.  The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder.

Authors:  Nursu Çakin Memik; Işık Karakaya; Özlem Yildiz; Şahika Şişmanlar; Çiğdem Çağlayan; Belma Ağaoğlu
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

10.  Functioning and disability levels in primary care out-patients with one or more anxiety disorders.

Authors:  C D Sherbourne; G Sullivan; M G Craske; P Roy-Byrne; D Golinelli; R D Rose; D A Chavira; A Bystritsky; M B Stein
Journal:  Psychol Med       Date:  2010-02-11       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.